Stock Report

All about this stock under one free report Last Updated: 27-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

HPC Biosciences Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 535217

₹25.68

up-down-arrow ₹-0.52 (-1.98%)

As on 29-Jul-2024IST

Market cap

info icon

₹410 Cr

Revenue (TTM)

info icon

₹2 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

12.5

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -25.87 90.55 5.53 4.12
EBIT -- 950.00 330.09 121.25 24.46
Net Profit -- 89.29 247.42 81.10 20.49
EPS -- 90.00 247.39 81.30 20.46
Book Value -- -- 3.69 2.21 1.91
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-21Mar-20Mar-19
EBIT-Margin info 33.4824.5348.4121.4530.58
Net Margin info 35.9927.6449.3225.8632.80
Return on equity info 2.161.763.621.071.78
Return on Capital info 2.231.873.691.141.86
Return on Assets info 2.131.743.581.051.75
Debt to Equity (x) info ----0.000.000.00

Profitability

View Detailed Peer Comparison

ROCE

3.69

Lower than Peers by 12.20

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
3.69
1.14
1.86
0.78
1.88
Peer Median
15.89
14.54
15.02
14.86
--
ROE

3.62

Lower than Peers by 10.80

Profit after tax / Average Net worth * 100

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
3.62
1.07
1.78
0.64
1.68
Peer Median
14.42
13.70
13.82
10.38
--
ROA

3.58

Lower than Peers by 3.23

Profit after tax / Average Total assets * 100

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
3.58
1.05
1.75
0.63
1.66
Peer Median
6.82
6.30
6.69
7.60
--
EBIT Margin

48.41

Higher than Peers by 38.45

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
48.41
21.45
30.58
5.25
16.96
Peer Median
9.96
5.88
8.94
8.76
--
Net Margin

49.32

Higher than Peers by 40.49

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
49.32
25.86
32.80
9.45
20.77
Peer Median
8.83
6.23
3.62
6.09
--
Cash Profit Margin

73.59

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
73.59
78.87
79.37
53.41
66.39
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

90.55

Higher than Peers by 68.83

Year on year growth in net sales

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
90.55
-25.03
-17.73
-13.87
20.91
Peer Median
21.72
3.49
20.51
16.76
--
EBIT Growth

330.09

Higher than Peers by 281.37

Year on year growth in operating profit (EBIT)

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
330.09
-47.42
378.90
-73.32
3.34
Peer Median
48.71
14.17
16.00
14.92
--
Net Profit Growth

247.42

Higher than Peers by 212.74

Year on year growth in profit after tax

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
247.42
-39.26
181.45
-61.22
10.27
Peer Median
34.68
37.23
30.39
10.50
--
EPS Growth

247.39

Higher than Peers by 212.79

Year on year growth in earnings per share

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
247.39
-39.23
182.31
-61.32
10.03
Peer Median
34.60
17.57
42.78
66.67
--
Book Value Growth

3.69

--

Year on year growth in book value per share

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
3.69
1.09
1.86
0.86
2.10
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
--
--
--
--
--
Peer Median
0.16
0.26
0.31
0.38
--
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
--
--
--
--
--
Peer Median
--
--
--
--
--
Current Ratio

92.99

Higher than Peers by 90.63

Current Assets / Current Liabilities and Provisions

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
92.99
53.95
42.49
47.41
52.59
Peer Median
2.36
2.47
1.79
2.02
--
Quick Ratio

91.04

Higher than Peers by 89.80

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
91.04
52.19
40.91
45.46
49.55
Peer Median
1.24
1.03
1.26
1.27
--
Interest Coverage

2,897.08

Higher than Peers by 2,882.19

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
2,897.08
1,956.75
369.11
28.83
150.94
Peer Median
14.89
11.10
10.48
9.13
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

249.39

Higher than Peers by 234.32

Debtors outstanding / Net Sales * 100

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
249.39
452.06
330.84
265.34
171.73
Peer Median
15.07
12.26
15.48
17.91
--
Asset Turnover

0.07

Lower than Peers by 1.25

Sales / Average Total Assets

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
0.07
0.04
0.05
0.06
0.07
Peer Median
1.32
1.27
2.03
1.59
--
Receivable days

888.10

--

Average Debtors / Sales * 365

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
888.10
1,630.41
1,192.36
848.13
577.12
Peer Median
--
--
--
--
--
Inventory Days

107.96

--

Average Inventory / Sales * 365

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
107.96
256.43
205.59
201.10
200.57
Peer Median
--
--
--
--
--
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
--
--
--
--
--
Peer Median
--
--
--
--
--
Cash Conversion Cycle

996.06

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
996.06
1,886.83
1,397.95
1,049.23
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
--
--
--
3,286.72
1,526.73
Peer Median
51.30
47.49
28.98
35.92
--
Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
--
--
--
21.03
25.40
Peer Median
4.47
2.67
3.70
3.00
--
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
--
--
--
--
--
Peer Median
0.16
0.18
--
0.01
--
EV/EBITDA

9.19

Lower than Peers by 14.80

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
9.19
16.17
12.12
598.21
496.53
Peer Median
23.98
22.51
16.05
15.36
--
Market Cap

--

--

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
HPC Biosciences
--
--
--
647
775
Peer Median
1,454
1,739
542
317
--
loading...
loading...
loading...